The vaccine is made from pieces of a protein called TARP that is found in 95 per cent of prostate cancers . 
  It teaches the immune system to recognise compounds found in cancer cells . 
  It is being given to men who have already been treated for the cancer . 
  Researchers at the U . 
 S . 
  National Cancer Institute are using the vaccine on 70 men whose PSA is rising again . 
  If successful it could be used as a first line treatment for prostate and potentially breast cancer . 
 